Form 4: Xencor Director Acquires Shares, Options Granted

Xencor Director Kurt A. Gustafson acquired 10,302 shares of common stock and was granted options for 20,604 shares, with vesting schedules detailed.

Summary

• Kurt A. Gustafson, a Director at Xencor Inc., acquired 10,302 shares of common stock on June 16, 2026.
• The acquisition of common stock was valued at $0, indicating it was likely a grant or award.
• Gustafson also received stock options for 20,604 shares of common stock on the same date.
• These options have an exercise price of $12.20 and are set to expire on June 15, 2036.
• The shares subject to the option will vest in equal monthly installments over one year, starting one month after June 16, 2026, fully vesting by June 16, 2027.
• The restricted stock units acquired shall fully vest on the first anniversary of the date of grant.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider equity awards rather than significant strategic shifts or financial performance indicators.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• Granting of stock options provides an incentive for the director to contribute to long-term shareholder value.
• Clear vesting schedules for both restricted stock units and options provide transparency.

Negatives

• The acquisition of common stock was at a price of $0, suggesting it was an award rather than an open market purchase, which might not reflect personal investment conviction.
• The exercise price of the options ($12.20) is significantly higher than the acquisition price of the common stock, indicating a potential for dilution or a need for substantial stock price appreciation to be profitable.

Risks

• The vesting schedule for options means that the director's full benefit from these options is contingent on continued service and stock price performance over the next year.
• If the stock price does not exceed $12.20 per share, the granted options may not be exercised, potentially impacting future executive compensation realization.

Future Outlook

The filing does not contain forward-looking statements or guidance. The details pertain to past transactions and future vesting schedules of equity awards.

Industry Context

StockSavvy.ai notes that insider transactions, such as those reported on Form 4, are closely watched by the market as they can provide insights into management's perception of the company's value and future prospects. The grant of options and RSUs is a common practice in the biotechnology sector to attract and retain key talent.

Stakeholder Impact

• Shareholders: The acquisition of stock by a director may be viewed positively, but the nature of the award (zero cost) and the option grant structure are standard compensation practices.
• Employees: The compensation structure aligns with industry norms for executive and director incentives.
• Management: The director receives equity awards that incentivize performance and retention.

Next Steps

• Vesting of stock options over the next year.
• Potential exercise of vested stock options if the stock price exceeds the $12.20 exercise price.

Key Dates

Keywords

Xencor, XNCR, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Beneficial Ownership, Director Compensation, Securities Exchange Act